Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03951792 · ClinicalTrials.gov registry record
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
A clinical trial of Gastrointestinal Disease and Cancer Colon, sponsored by Mayo Clinic.
- Completed
- Registry status
- 220
- Enrollment target
- 1
- Study location
NCT03951792 is a study of Gastrointestinal Disease and Cancer Colon that has completed, run by Mayo Clinic. The registered enrollment target is 220 participants, below the 2,385-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03951792, a study of Gastrointestinal Disease and Cancer Colon, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2024-03-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03951792
The ClinicalTrials.gov registry entry for NCT03951792 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,385-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastrointestinal Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03951792 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03951792 about?
NCT03951792 is a clinical study titled "Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects". Researchers are trying to determine whether certain microbiome cause cancer or whether they are part of the microbiome in the gut due to the presence of cancer.
What is the current status of trial NCT03951792?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2019-05-28. Estimated completion is 2024-03-15.
What conditions does trial NCT03951792 study?
This clinical trial studies the following conditions: Gastrointestinal Disease, Cancer Colon.
Who is sponsoring clinical trial NCT03951792?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03951792 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Nursing Practices in Hospital Oncology Care
ACTIVE NOT RECRUITING · NA
-
Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy
ACTIVE NOT RECRUITING · NA
-
Optimizing Gastrointestinal Procedure Appointments
COMPLETED · NA
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
FDG-PET-CT and Biomarkers in Esophageal Cancer
COMPLETED · NA
-
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.